Loading...
XNYS
CNMD
Market cap1.24bUSD
Dec 05, Last price  
40.07USD
1D
-9.43%
1Q
-27.11%
Jan 2017
-9.28%
Name

Conmed Corp

Chart & Performance

D1W1MN
XNYS:CNMD chart
P/E
9.37
P/S
0.95
EPS
4.28
Div Yield, %
1.50%
Shrs. gr., 5y
1.07%
Rev. gr., 5y
6.47%
Revenues
1.31b
+5.00%
617,305,000646,812,000694,288,000742,183,000694,739,000713,723,000725,077,000767,140,000756,755,000734,467,000719,168,000763,520,000796,392,000859,634,000955,097,000862,459,0001,010,635,0001,045,472,0001,244,744,0001,307,015,000
Net income
132m
+105.44%
31,994,000-12,507,00041,456,00044,561,00012,137,00030,346,000752,00040,481,00035,939,00032,192,00030,498,00014,664,00055,487,00040,854,00028,620,0009,517,00062,542,000-80,582,00064,459,000132,423,000
CFO
167m
+33.20%
42,434,00064,572,00065,894,00061,149,00025,028,00038,243,000102,993,00095,199,00080,949,00065,176,00048,068,00038,222,00065,566,00074,701,00095,133,00064,531,000111,770,00033,365,000125,348,000166,968,000
Dividend
Sep 16, 20240.2 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
IPO date
Jul 23, 1987
Employees
4,100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT